CM Hospitalar S/A

VVEO3

BRVVEOACNOR0

Pharmaceuticals

Market Closed - Sao Paulo Other stock markets 01:37:00 18/07/2024 am IST			5-day change	1st Jan Change
2.4 ^BRL	-2.83%		-8.75%	-82.80%

10/05	CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/03	CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	CI

CM Hospitalar S/A singed a purchase and sale agreement to acquire Expressa Distribuidora De Medicamentos Ltda.

January 10, 2020

CM Hospitalar S/A singed a purchase and sale agreement to acquire Expressa Distribuidora De Medicamentos Ltda on December 27, 2019. In 2019, Expressa Distribuidora generated revenue of BRL 1.5 billion. Transaction is subject to approval by the Brazilian antitrust body Cade.

As of May 25, 2020 the transaction was approved by CADE. Fernando Meira of Pinheiro Neto Advogados acted as legal advisor to selleing shareholder of Expressa Distribuidora De Medicamentos. Rodrigo Marcilio of Pinheiro Guimarães - Advogados acted as legal advisor to CM Hospitalar S/A.

Latest news about CM Hospitalar S/A

CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/03	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index	29/12	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	10/23/10	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	10/23/10	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
CM Hospitalar S/A acquired remaining stake in Far.me.	06/23/06	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.	24/22/24	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/22/10	CI
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions	08/22/08	RE
CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.	11/22/11	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2022	10/22/10	CI
CM Hospitalar S/A acquired Boxifarma.	19/22/19	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2021	11/22/11	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	11/22/11	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to S&P Global BMI Index	20/21/20	CI
CM Hospitalar S/A acquired Macromed Produtos Hospitalares Ltda.	16/21/16	CI
CM Hospitalar S/A entered into Purchase and Sale agreement to acquire Laborsys Produtos Produtos e Hospitalares Ltda.	12/21/12	CI
CM Hospitalar S/A has completed an IPO in the amount of BRL 1.87698 billion.	06/21/06	CI

Chart CM Hospitalar S/A

Duration

Period

More charts

Company Profile

CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for CM Hospitalar S/A

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.4 BRL

Average target price

7.725 BRL

Spread / Average Target

+221.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CM HOSPITALAR S/A	-82.80%	140M
MCKESSON CORPORATION	+25.72%	75.5B
CARDINAL HEALTH, INC.	-4.79%	23.38B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+17.81%	8.96B
HUADONG MEDICINE CO., LTD	-31.67%	6.83B
H. LUNDBECK A/S	+21.55%	5.59B
GALENICA AG	+3.99%	4.26B
EBOS GROUP LIMITED	-3.94%	4B
MEDIPAL HOLDINGS CORPORATION	+13.98%	3.49B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+10.59%	3.29B

Pharmaceuticals Wholesale

CM Hospitalar S/A

Equities

VVEO3

BRVVEOACNOR0

Pharmaceuticals

CM Hospitalar S/A singed a purchase and sale agreement to acquire Expressa Distribuidora De Medicamentos Ltda.

EPS Revisions